Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1981 1
1984 1
1985 1
1988 2
1989 1
1990 1
1991 3
1992 1
1993 6
1994 1
1995 4
1996 4
1997 5
1998 2
1999 5
2000 7
2001 6
2002 9
2003 7
2004 9
2005 7
2006 5
2007 7
2008 14
2009 17
2010 14
2011 11
2012 9
2013 13
2014 14
2015 9
2016 22
2017 12
2018 10
2019 14
2020 14
2021 7
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19161758

254 results

Results by year

Filters applied: . Clear all
Page 1
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, Kuitunen AH, Kuttila KT, Peräkylä TK, Sarapohja T, Suojaranta-Ylinen RT, Valtonen M, Salmenperä MT. Eriksson HI, et al. Ann Thorac Surg. 2009 Feb;87(2):448-54. doi: 10.1016/j.athoracsur.2008.10.029. Ann Thorac Surg. 2009. PMID: 19161758 Clinical Trial.
Preoperative levosimendan in ischemic mitral valve repair.
Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Sharma P, et al. Asian Cardiovasc Thorac Ann. 2014 Jun;22(5):539-45. doi: 10.1177/0218492313499352. Epub 2013 Oct 25. Asian Cardiovasc Thorac Ann. 2014. PMID: 24867027 Clinical Trial.
Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
Anastasiadis K, Antonitsis P, Vranis K, Kleontas A, Asteriou C, Grosomanidis V, Tossios P, Argiriadou H. Anastasiadis K, et al. Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):740-747. doi: 10.1093/icvts/ivw213. Epub 2016 Jul 4. Interact Cardiovasc Thorac Surg. 2016. PMID: 27378790 Clinical Trial.
Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G; -. Cholley B, et al. JAMA. 2017 Aug 8;318(6):548-556. doi: 10.1001/jama.2017.9973. JAMA. 2017. PMID: 28787507 Free PMC article. Clinical Trial.
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Mehta RH, Van Diepen S, Meza J, Bokesch P, Leimberger JD, Tourt-Uhlig S, Swartz M, Parrotta J, Jankowich R, Hay D, Harrison RW, Fremes S, Goodman SG, Luber J, Toller W, Heringlake M, Anstrom KJ, Levy JH, Harrington RA, Alexander JH; LEVO-CTS Investigators. Mehta RH, et al. Am Heart J. 2016 Dec;182:62-71. doi: 10.1016/j.ahj.2016.09.001. Epub 2016 Sep 9. Am Heart J. 2016. PMID: 27914501 Clinical Trial.
254 results